Oscar Health, Inc. (OSCR) shares surged 15.13% in pre-market trading on Friday, as investors reacted to the company's exceptional Q1 2025 results and the potential impact of proposed Medicare Part E legislation. The tech-native insurer has successfully transformed from a money-losing startup to a profitable growth story, validating its digital-first model in the health insurance industry.
The company reported a net income of $275 million on $3 billion in revenue for Q1 2025, representing a 42% year-over-year growth. This performance significantly exceeded analyst expectations, with diluted earnings per share of $0.92 surpassing consensus estimates by over 14%. Oscar Health's operational improvements were evident in its record-low SG&A ratio of 15.8% and an improved medical loss ratio of 75.4%.
Adding to the optimism surrounding Oscar Health is the recently introduced Choose Medicare Act, which proposes a Medicare Part E public option available through ACA marketplaces. If passed, this legislation could substantially expand Oscar's addressable market, potentially tripling it. The company's established infrastructure and experience in operating profitably in individual markets through digital distribution on government exchanges position it favorably to capitalize on this potential opportunity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。